Efficacy evaluation of chimeric antigen receptor-modified human peritoneal macrophages in the treatment of gastric cancer.
Xuhui DongJiqiang FanWangxu XieXiang WuJia WeiZhonglei HeWenxin WangXueting WangPingping ShenYuncheng BeiPublished in: British journal of cancer (2023)
HF-CAR-PMs could represent an exciting therapeutic option for patients with HER2-positive GC cancer, which should be tested in carefully designed clinical trials.